国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2010年
8期
1463-1466
,共4页
脉络膜血管瘤%敷贴照射%经瞳孔温热疗法
脈絡膜血管瘤%敷貼照射%經瞳孔溫熱療法
맥락막혈관류%부첩조사%경동공온열요법
circumscribed choroidal haemangioma%plaque brachytherapy%transpupillary thermotherapy
目的:描述第三级转诊中心15a期间局限性脉络膜血管瘤(CCH)患者光动力疗法的临床经验.方法:对1992/2007年第三级转诊中心确诊(基本数据和摄影记录为主要确诊依据)为局限性脉络膜血管瘤患者进行记录.结果:患者11例(69%)视力改善(>2行),1例(5%)患者视力保持稳定,4例(25%)患者恶化.6/7患者采用放疗的方法和3/4采用瞳孔温热疗法治疗均获得了良好的效果.86%的患者发病6mo内进行治疗和50%的患者发病6mo后进行治疗视力有明显的改善.只有一个患者视力<6/60.平均随访时间为35mo.结论:发病6mo内进行治疗的患者效果较好.多数患者经过治疗后视力显著改善且无任何不良影响.
目的:描述第三級轉診中心15a期間跼限性脈絡膜血管瘤(CCH)患者光動力療法的臨床經驗.方法:對1992/2007年第三級轉診中心確診(基本數據和攝影記錄為主要確診依據)為跼限性脈絡膜血管瘤患者進行記錄.結果:患者11例(69%)視力改善(>2行),1例(5%)患者視力保持穩定,4例(25%)患者噁化.6/7患者採用放療的方法和3/4採用瞳孔溫熱療法治療均穫得瞭良好的效果.86%的患者髮病6mo內進行治療和50%的患者髮病6mo後進行治療視力有明顯的改善.隻有一箇患者視力<6/60.平均隨訪時間為35mo.結論:髮病6mo內進行治療的患者效果較好.多數患者經過治療後視力顯著改善且無任何不良影響.
목적:묘술제삼급전진중심15a기간국한성맥락막혈관류(CCH)환자광동력요법적림상경험.방법:대1992/2007년제삼급전진중심학진(기본수거화섭영기록위주요학진의거)위국한성맥락막혈관류환자진행기록.결과:환자11례(69%)시력개선(>2행),1례(5%)환자시력보지은정,4례(25%)환자악화.6/7환자채용방료적방법화3/4채용동공온열요법치료균획득료량호적효과.86%적환자발병6mo내진행치료화50%적환자발병6mo후진행치료시력유명현적개선.지유일개환자시력<6/60.평균수방시간위35mo.결론:발병6mo내진행치료적환자효과교호.다수환자경과치료후시력현저개선차무임하불량영향.
AIM:To describe our clinical experience in treating circumscribed choroidal haemangioma(CCH)in a tertiary referral centre over a fifteen year period prior to photodynamic therapy.METHODS:The departmental database and photographic records of a tertiary referral center were used to identify patients who were treated for CCH between 1992 and 2007.Their case records were reviewed.RESULTS:Visual acuity improved(>2 Snellen lines)in eleven patients(69%)remained stable in one patient (6%)and deteriorated in four patients(25%).Six of the seven treated with brachytherapy and three of the four treated with transpupillary thermotherapy achieved better visual acuity after treatment.86% of patients treated within six months of onset of symptoms and 50% of patients treated after six months of onset of symptoms noted an improvement in visual acuity.Only one patient in our series had a final VA of 6/60 or worse.Mean follow-up was thirty-five months.CONCLUSION:Visual outcome is better when treatment is performed within 6 months of symptoms.The majority of patients achieved an improvement in visual acuity without any adverse effect following treatment.